Abstract
The treatment of patients with cervical lymph node metastases without detectable primary tumor remains an important challenge, until today, no standard therapy is available. The present study investigated the multimodal treatment of patients with head and neck CUP syndrome (HNCUP) and their follow-up retrospectively. 81 patients with cervical lymph node metastases without a primary tumor were treated at the Departments of Otorhinolaryngology as well as Radiotherapy and Radiation Oncology at the University of Saarland in Homburg, Germany in the period between 1991 and 2013. All patients received routine work-up consisting of CUP panendoscopy and imaging. Neck dissection was then performed in 77% of the patients. The most common histology was squamous cell carcinoma (80%). Ten percent of the patients had distant metastases. All patients underwent primary or adjuvant radiation therapy, or simultaneous radiochemotherapy. After a median follow-up of 3.5 years, the 5-year survival rate was 30%. There was a local recurrence that was known in 20/63 patients (31%) and distant metastases were documented in 19/61 M0 patients (31%). Higher grade late toxicity (grade 3–4) was observed in 12% of patients. Neck dissection and radiation therapy remains an integral part of HNCUP therapy, while the use of chemotherapy could be considered in selected cases. Prospective multicenter randomized trials would be necessary to identify the best target volume and to clarify the role of chemotherapy.
Similar content being viewed by others
References
Pavlidis N, Pentheroudakis G (2012) Cancer of unknown primary site. Lancet 379:1428–1435
Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB (2000) Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 55:121–129
Rödel RM, Matthias C, Blomeyer BD, Wolff HA, Jung K, Christiansen H (2009) Impact of distant metastasis in patients with cervical lymph node metastases from cancer of an unknown primary site. Ann Otol Rhinol Laryngol 118:662–669
Koivunen P, Laranne J, Virtaniemi J, Bäck L, Mäkitie A, Pulkkinen J, Grenman R (2002) Cervical metastasis of unknown origin: a series of 72 patients. Acta Otolaryngol 122:569–574
Mozet C, Wichmann G, Stumpp P, Dietzsch S, Dietz A (2013) Zervikales cup-syndrom. Der Onkologe 19:44–51
Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW (1991) Standardizing neck dissection terminology. Official report of the Academy’s Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 117:601–605
Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A, Som P, Wolf GT; American Head and Neck Society; American Academy of Otolaryngology–Head and Neck Surgery (2002) Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 128:751–758
Doty J, Gossman D, Kudrimoti M, Valentino J, Arnold S, Spring P (2006) Analysis of unknown primary carcinomas metastatic to the neck: diagnosis, treatment, and outcomes. J Ky Med Assoc 104:57–64
Jereczek-Fossa BA, Jassem J, Orecchia R (2004) Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 30:153–164
Strojan P, Ferlito A, Medina JE, Woolgar JA, Rinaldo A, Robbins KT, Fagan JJ, Mendenhall WM, Paleri V, Silver CE, Olsen KD, Corry J, Suárez C, Rodrigo JP, Langendijk JA, Devaney KO, Kowalski LP, Hartl DM, Haigentz M Jr, Werner JA, Pellitteri PK, de Bree R, Wolf GT, Takes RP, Genden EM, Hinni ML, Mondin V, Shaha AR, Barnes L (2013) Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck 35:123–132
Strojan P, Ferlito A, Langendijk JA, Corry J, Woolgar JA, Rinaldo A, Silver CE, Paleri V, Fagan JJ, Pellitteri PK, Haigentz M Jr, Suárez C, Robbins KT, Rodrigo JP, Olsen KD, Hinni ML, Werner JA, Mondin V, Kowalski LP, Devaney KO, de Bree R, Takes RP, Wolf GT, Shaha AR, Genden EM, Barnes L (2013) Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of therapeutic options. Head Neck 35:286–293
Argiris A, Smith S, Stenson K, Mittal B, Pelzer H, Kies M, Haraf D, Vokes E (2003) Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Ann Oncol 14:1306–1311
Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341–1346
Christiansen H, Hermann RM, Martin A, Nitsche M, Schmidberger H, Pradier O (2005) Neck lymph node metastases from an unknown primary tumor retrospective study and review of literature. Strahlenther Onkol 181:355–362
Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP (2001) Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection. Int J Radiat Oncol Biol Phys 50:55–63
Fakhrian K, Thamm R, Knapp S, Molls M, Pigorsch S, Haller B, Geinitz H (2012) Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis. Strahlenther Onkol 188:56–61
Guntinas-Lichius O, Peter Klussmann J, Dinh S, Dinh M, Schmidt M, Semrau R, Mueller RP (2006) Diagnostic work-up and outcome of cervical metastases from an unknown primary. Acta Otolaryngol 126:536–544
Beldì D, Jereczek-Fossa BA, D’Onofrio A, Gambaro G, Fiore MR, Pia F, Chiesa F, Orecchia R, Krengli M (2007) Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients. Int J Radiat Oncol Biol Phys 69:1051–1058
Hauswald H, Lindel K, Rochet N, Debus J, Harms W (2008) Surgery with complete resection improves survival in radiooncologically treated patients with cervical lymph node metastases from cancer of unknown primary. Strahlenther Onkol 184:150–156
Aslani M, Sultanem K, Voung T, Hier M, Niazi T, Shenouda G (2007) Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Head Neck 29:585–590
Ligey A, Gentil J, Créhange G, Montbarbon X, Pommier P, Peignaux K, Truc G, Maingon P (2009) Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary. Radiother Oncol 93:483–487
Werner JA (2002) Lymphknotenerkrankungen im Kopf-Hals-Bereich: Onkologie und Differentialdiagnostik. Springer, Heidelberg
Wallace A, Richards GM, Harari PM, Kirwan JM, Morris CG, Katakam H, Mendenhall WM (2011) Head and neck squamous cell carcinoma from an unknown primary site. Am J Otolaryngol 32:286–290
Lu X, Hu C, Ji Q, Shen C, Feng Y (2009) Squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: the impact of radiotherapy. Tumori 95:185–190
Perkins SM, Spencer CR, Chernock RD, Haughey BH, Nussenbaum B, Adkins DR, Kuperman DI, Thorstad WL (2012) Radiotherapeutic management of cervical lymph node metastases from an unknown primary site. Arch Otolaryngol Head Neck Surg 138:656–661
Boscolo-Rizzo P, Gava A, Da Mosto MC (2007) Carcinoma metastatic to cervical lymph nodes from an occult primary tumor: the outcome after combined-modality therapy. Ann Surg Oncol 14:1575–1582
Patel RS, Clark J, Wyten R, Gao K, O’Brien CJ (2007) Squamous cell carcinoma from an unknown head and neck primary site: a “selective treatment” approach. Arch Otolaryngol Head Neck Surg 133:1282–1287
Issing WJ, Taleban B, Tauber S (2003) Diagnosis and management of carcinoma of unknown primary in the head and neck. Eur Arch Otorhinolaryngol 260:436–443
Iganej S, Kagan R, Anderson P, Rao A, Tome M, Wang R, Dowlatshahi M, Cosmatos H, Morgan T (2002) Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse. Head Neck 24:236–246
Fernández JA, Suárez C, Martínez JA, Llorente JL, Rodrigo JP, Alvarez JC (1998) Metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary tumour: prognostic factors. Clin Otolaryngol Allied Sci 23:158–163
Sinnathamby K, Peters LJ, Laidlaw C, Hughes PG (1997) The occult head and neck primary: to treat or not to treat? Clin Oncol (R Coll Radiol) 9:322–329
Chen AM, Farwell DG, Lau DH, Li BQ, Luu Q, Donald PJ (2011) Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio? Int J Radiat Oncol Biol Phys 81:346–352
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Al Kadah Basel, Papaspyrou Giorgos, Linxweiler Maximilian, Schick Bernhard, Rübe Christian, Büchler Simeon Benjamin, and Niewald Marcus declares that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Al Kadah, B., Papaspyrou, G., Linxweiler, M. et al. Cancer of unknown primary (CUP) of the head and neck: retrospective analysis of 81 patients. Eur Arch Otorhinolaryngol 274, 2557–2566 (2017). https://doi.org/10.1007/s00405-017-4525-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-017-4525-8